Peter Bentham Roger T Staff Bjoern O Schelter Helen Shiells Charles R Harrington Claude M Wischik
10.3233/JAD-210390
J Alzheimers Dis
2021;83(3):1017-1023.
frontotemporal dementia p301s hydromethylthionine leucomethylthioninium microtubule-associated protein tau
CC BY
https://pubmed.ncbi.nlm.nih.gov/34366349/
Atrophy / pathology Atrophy / prevention & control Carrier State Frontotemporal Dementia / drug therapy Frontotemporal Dementia / genetics Methylene Blue / analogs & derivatives Mutation / genetics tau Proteins / genetics
Atrophy / pathology Atrophy / prevention & control Carrier State Frontotemporal Dementia / drug therapy Frontotemporal Dementia / genetics Methylene Blue / analogs & derivatives Mutation / genetics tau Proteins / genetics Case Reports Letter Adult Brain / pathology Humans Magnetic Resonance Imaging Male Methylene Blue / administration & dosage Time Factors MAPT protein, human tau Proteins hydromethylthionine Methylene Blue
PMC8543267
34366349
Long-Term Hydromethylthionine Treatment Is Associated with Delayed Clinical Onset and Slowing of Cerebral Atrophy in a Pre-Symptomatic P301S MAPT Mutation Carrier
2021